Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.45 Insider Own59.32% Shs Outstand- Perf Week-3.86%
Market Cap19.55M Forward P/E- EPS next Y-0.04 Insider Trans0.00% Shs Float57.07M Perf Month-5.87%
Income-44.92M PEG- EPS next Q-0.02 Inst Own2.43% Short Float / Ratio0.21% / 0.47 Perf Quarter-27.66%
Sales42.99M P/S0.45 EPS this Y9.64% Inst Trans-3.27% Short Interest0.12M Perf Half Y-30.30%
Book/sh0.67 P/B0.21 EPS next Y89.47% ROA-18.56% Target Price1.52 Perf Year-38.13%
Cash/sh0.05 P/C2.83 EPS next 5Y- ROE-25.54% 52W Range0.13 - 0.47 Perf YTD-13.23%
Dividend- P/FCF- EPS past 5Y22.12% ROI-41.18% 52W High-70.21% Beta1.92
Dividend %- Quick Ratio0.38 Sales past 5Y- Gross Margin23.82% 52W Low4.03% ATR0.01
Employees- Current Ratio0.46 Sales Q/Q-64.47% Oper. Margin-87.28% RSI (14)40.39 Volatility11.51% 9.41%
OptionableNo Debt/Eq0.66 EPS Q/Q39.45% Profit Margin-104.47% Rel Volume0.94 Prev Close0.14
ShortableYes LT Debt/Eq0.16 EarningsAug 14 BMO Payout- Avg Volume259.92K Price0.14
Recom1.00 SMA20-3.42% SMA50-15.85% SMA200-35.39% Volume243,254 Change-1.13%
Date Action Analyst Rating Change Price Target Change
Jun-24-20Initiated Aegis Capital Buy $14
Jul-22-13Initiated Dawson James Buy $4
Nov-28-23 08:10AM
Nov-15-23 01:57PM
Nov-14-23 08:00AM
Nov-08-23 08:31AM
Oct-26-23 05:25PM
08:25AM Loading…
Oct-23-23 08:25AM
Oct-12-23 08:25AM
Sep-06-23 08:40AM
Aug-29-23 05:40AM
Jul-31-23 08:15AM
Jul-27-23 09:00AM
Jul-12-23 09:00AM
Jul-05-23 08:15AM
Jun-30-23 09:34AM
Jun-27-23 09:15AM
08:20AM Loading…
Jun-26-23 08:20AM
Jun-13-23 07:00AM
May-17-23 11:07AM
May-16-23 09:00AM
May-01-23 08:25AM
Apr-19-23 09:08AM
Apr-18-23 07:00AM
Apr-17-23 10:00AM
Apr-11-23 09:10AM
Mar-27-23 09:00AM
Mar-22-23 08:05AM
Mar-13-23 09:25AM
Mar-07-23 09:25AM
Mar-02-23 08:30AM
Nov-17-22 10:05AM
08:00AM Loading…
Oct-19-22 08:00AM
Sep-22-22 09:15AM
Aug-30-22 04:45PM
Jul-26-22 08:00AM
Jul-21-22 05:00PM
Jul-13-22 08:00AM
Jun-28-22 08:00AM
Jun-07-22 07:00AM
May-19-22 11:10AM
May-06-22 08:30AM
Apr-07-22 10:15AM
Mar-03-22 08:00AM
Feb-28-22 05:15PM
Feb-22-22 05:00PM
Jan-25-22 04:30PM
Jan-20-22 08:45AM
Jan-19-22 03:57PM
Jan-12-22 08:30AM
Jan-11-22 10:00AM
Jan-10-22 08:30AM
Jan-03-22 11:04AM
Dec-22-21 07:30AM
Dec-20-21 10:10AM
Dec-15-21 07:30AM
Dec-07-21 07:30AM
Dec-01-21 05:15AM
Nov-30-21 07:30AM
Nov-04-21 09:00AM
Oct-28-21 08:00AM
Oct-20-21 08:00AM
Oct-05-21 08:00AM
Sep-20-21 07:30AM
Sep-13-21 09:32AM
Sep-09-21 07:00AM
Sep-08-21 07:00AM
Sep-07-21 08:00AM
Sep-02-21 06:25AM
Aug-23-21 01:52PM
Aug-17-21 08:30AM
Aug-02-21 09:45AM
Jul-27-21 08:00AM
Jul-12-21 08:00AM
Jul-06-21 08:30AM
Jun-30-21 08:30AM
Jun-24-21 09:10AM
Jun-17-21 10:00AM
Jun-16-21 09:00AM
Jun-15-21 08:54AM
Jun-14-21 08:08PM
May-24-21 09:31AM
May-20-21 12:15PM
May-19-21 08:30AM
May-11-21 08:45AM
Apr-21-21 06:55AM
Apr-19-21 05:00AM
Apr-08-21 09:05AM
Apr-07-21 09:15AM
Apr-06-21 12:39PM
Mar-31-21 08:15AM
Mar-01-21 07:30AM
Feb-25-21 08:45AM
Feb-09-21 02:15PM
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chan Heng Fai AmbroseDirectorDec 13Buy0.23334,92175,89318,914,326Dec 14 08:39 PM
Chan Heng Fai AmbroseDirectorDec 09Buy0.1951,3859,92218,579,405Dec 13 04:30 PM